Reporting and Methods in Developing Prognostic Prediction Models for Metabolic Syndrome: A Systematic Review and Critical Appraisal

References

• Wilson PWF, D’Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005;112(20):3066–3072. doi:10.1161/CIRCULATIONAHA.105.539528
   PubMed Web of Science ®Google Scholar
• Semnani-Azad Z, Khan TA, Blanco Mejia S, et al. Association of major food sources of fructose-containing sugars with incident metabolic syndrome: a systematic review and meta-analysis. JAMA Netw Open. 2020;3(7):e209993. doi:10.1001/jamanetworkopen.2020.9993
   PubMedGoogle Scholar
• Moore JX, Chaudhary N, Akinyemiju TA. Metabolic syndrome prevalence by race/ethnicity and sex in the United States, National Health and Nutrition Examination Survey, 1988–2012. Prev Chronic Dis. 2017;14:160287. doi:10.5888/pcd14.160287
   Google Scholar
• Lu JL, Wang LM, Li M, et al. Metabolic syndrome among adults in China: the 2010 China Noncommunicable Disease Surveillance. J Clin Endocr Metab. 2017;102(2):507–515.
   PubMed Web of Science ®Google Scholar
• Sergi G, Dianin M, Bertocco A, et al. Gender differences in the impact of metabolic syndrome components on mortality in older people: a systematic review and meta-analysis. Nutr Metab Cardiovasc Dis. 2020.
   PubMedGoogle Scholar
• Zheng X, Yu H, Qiu X, Ying CS. The effects of a nurse-led lifestyle intervention program on cardiovascular risk, self-efficacy and health promoting behaviours among patients with metabolic syndrome: randomized controlled trial. Int J Nurs Stud. 2020;2020:103638.
   Google Scholar
• Moons KG, Royston P, Vergouwe Y, Grobbee DE. Prognosis and prognostic research: what, why, and how? BMJ. 2009;338:b375.
   PubMed Web of Science ®Google Scholar
• Steyerberg EW, Moons KG, van der Windt DA, et al. Prognosis Research Strategy (PROGRESS) 3: prognostic model research. PLoS Med. 2013;10(2):e1001381.
   PubMed Web of Science ®Google Scholar
• Damen J, Hooft L. The increasing need for systematic reviews of prognosis studies: strategies to facilitate review production and improve quality of primary research. Diagn Progn Res. 2019;3:2.
   PubMedGoogle Scholar
• Ibrahim MS, Pang D, Pappas Y, Randhawa G. Metabolic syndrome risk models and scores: a systematic review. Biomed J Sci Tech Res. 2020;26(1):19695–19707.
   Google Scholar
• Ibrahim MS, Pang D, Randhawa G, Pappas Y. Risk models and scores for metabolic syndrome: systematic review protocol. BMJ Open. 2019;9(9):e027326. doi:10.1136/bmjopen-2018-027326
   PubMed Web of Science ®Google Scholar
• Cochrane handbook for systematic reviews of interventions: the Cochrane Collaboration; 2011. Available from: http://handbook-5-1.cochrane.org/. Accessed November 23, 2020.
   Google Scholar
• Wynants L, Van Calster B, Collins GS, et al. Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal. BMJ. 2020;369:m1328.
   PubMed Web of Science ®Google Scholar
• Ensor J, Riley RD, Moore D, Snell KI, Bayliss S, Fitzmaurice D. Systematic review of prognostic models for recurrent venous thromboembolism (VTE) post-treatment of first unprovoked VTE. BMJ Open. 2016;6(6):e011190. doi:10.1136/bmjopen-2016-011190
   Google Scholar
• Moons KGM, de Groot JAH, Bouwmeester W, et al. Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist. PLoS Med. 2014;11(10):e1001744. doi:10.1371/journal.pmed.1001744
   PubMed Web of Science ®Google Scholar
• Moons KGM, Wolff RF, Riley RD, et al. PROBAST: a tool to assess risk of bias and applicability of prediction model studies: explanation and elaboration. Ann Intern Med. 2019;170(1):W1–W33. doi:10.7326/M18-1377
   PubMed Web of Science ®Google Scholar
• Collins GS, Reitsma JB, Altman DG, Moons KGM. Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): the TRIPOD Statement. Br J Surg. 2015;102(3):148–158. doi:10.1002/bjs.9736
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG. The PRISMA Group (2009) Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med. 2009;6(7):e1000097. doi:10.1371/journal.pmed.1000097
   Google Scholar
• Gao YS, Bd L. Bayesian model averaging method for predicting 5 years of metabolic syndrome risk in men and women. Shandong Med J. 2016;56(39):91–94.
   Google Scholar
• Hirose H, Takayama T, Hozawa S, Hibi T, Saito I. Prediction of metabolic syndrome using artificial neural network system based on clinical data including insulin resistance index and serum adiponectin. Comput Biol Med. 2011;41(11):1051–1056. doi:10.1016/j.compbiomed.2011.09.005
   PubMedGoogle Scholar
• Hsiao F-C, Wu C-Z, Hsieh C-H, He C-T, Hung Y-J, Pei D. Chinese metabolic syndrome risk score. South Med J. 2009;102(2):159–164. doi:10.1097/SMJ.0b013e3181836b19
   PubMed Web of Science ®Google Scholar
• Obokata M, Negishi K, Ohyama Y, Okada H, Imai K, Kurabayashi M. A risk score with additional four independent factors to predict the incidence and recovery from metabolic syndrome: development and validation in large Japanese cohorts. PLoS One. 2015;10(7):7. doi:10.1371/journal.pone.0133884
   Google Scholar
• Ohyama Y. Risk prediction model of metabolic syndrome in health management Population. J Shandong Univ. 2017;6(55):87–92.
   Google Scholar
• Yang X, Tao Q, Sun F, Cao C, Zhan S. Setting up a risk prediction model on metabolic syndrome among 35–74 year-olds based on the Taiwan MJ Health-checkup Database. Zhonghua Liuxingbingxue Zazhi. 2013;34(9):874–878.
   Google Scholar
• Zhang W, Chen Q, Yuan Z, et al. A routine biomarker-based risk prediction model for metabolic syndrome in urban Han Chinese population. BMC Public Health. 2015;15(1):64. doi:10.1186/s12889-015-1424-z
   PubMedGoogle Scholar
• Zou -T-T, Zhou Y-J, Zhou X-D, et al. MetS risk score: a clear scoring model to predict a 3-year risk for metabolic syndrome. Hormone Metab Res. 2018;50(9):683–689. doi:10.1055/a-0677-2720
   PubMedGoogle Scholar
• Karimi-Alavijeh F, Jalili S, Sadeghi M. Predicting metabolic syndrome using decision tree and support vector machine methods. ARYA Atheroscler. 2016;12(3):146–152.
   PubMedGoogle Scholar
• Pujos-Guillot E, Brandolini M, Petera M, et al. Systems metabolomics for prediction of metabolic syndrome. J Proteome Res. 2017;16(6):2262–2272. doi:10.1021/acs.jproteome.7b00116
   PubMedGoogle Scholar
• Efstathiou SP, Skeva II, Zorbala E, Georgiou E, Mountokalakis TD. Metabolic syndrome in adolescence can it be predicted from natal and parental profile? The Prediction of Metabolic Syndrome in Adolescence (PREMA) study. Circulation. 2012;125(7):902–910. doi:10.1161/CIRCULATIONAHA.111.034546
   PubMedGoogle Scholar
• Ganna A, Reilly M, de Faire U, Pedersen N, Magnusson P, Ingelsson E. Risk prediction measures for case-cohort and nested case-control designs: an application to cardiovascular disease. Am J Epidemiol. 2012;175(7):715–724. doi:10.1093/aje/kwr374
   PubMedGoogle Scholar
• Ogundimu EO, Altman DG, Collins GS. DG, GS C. Adequate sample size for developing prediction models is not simply related to events per variable. J Clin Epidemiol. 2016;76:175–182. doi:10.1016/j.jclinepi.2016.02.031
   PubMed Web of Science ®Google Scholar
• van der Ploeg T, Austin PC, Steyerberg EW. Modern modelling techniques are data hungry: a simulation study for predicting dichotomous endpoints. BMC Med Res Methodol. 2014;14(1):137. doi:10.1186/1471-2288-14-137
   PubMedGoogle Scholar
• Courvoisier DS, Combescure C, Agoritsas T, Gayet-Ageron A, Perneger TV. Performance of logistic regression modeling: beyond the number of events per variable, the role of data structure. J Clin Epidemiol. 2011;64(9):993–1000. doi:10.1016/j.jclinepi.2010.11.012
   PubMed Web of Science ®Google Scholar
• Vergouwe Y, Steyerberg EW, Eijkemans MJC, Habbema JDF. Substantial effective sample sizes were required for external validation studies of predictive logistic regression models. J Clin Epidemiol. 2005;58(5):475–483. doi:10.1016/j.jclinepi.2004.06.017
   PubMed Web of Science ®Google Scholar
• Vergouwe Y, Royston P, Moons KGM, Altman DG. Development and validation of a prediction model with missing predictor data: a practical approach. J Clin Epidemiol. 2010;63(2):205–214. doi:10.1016/j.jclinepi.2009.03.017
   PubMedGoogle Scholar
• Marshall A, Altman DG, Royston P, Holder RL. Comparison of techniques for handling missing covariate data within prognostic modelling studies: a simulation study. BMC Med Res Methodol. 2010;10.
   PubMedGoogle Scholar
• Royston P, Altman DG, Sauerbrei W. Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med. 2006;25(1):127–141. doi:10.1002/sim.2331
   PubMed Web of Science ®Google Scholar
• Collins GS, Ogundimu EO, Cook JA, Manach YL, Altman DG. Quantifying the impact of different approaches for handling continuous predictors on the performance of a prognostic model. Stat Med. 2016;35(23):4124–4135. doi:10.1002/sim.6986
   PubMed Web of Science ®Google Scholar
• Steyerberg EW. Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating. New York: Springer; 2019.
   Google Scholar
• Royston P, Moons KG, Altman DG, Vergouwe Y. Prognosis and prognostic research: developing a prognostic model. BMJ. 2009;338(mar31 1):b604. doi:10.1136/bmj.b604
   PubMed Web of Science ®Google Scholar
• Pavlou M, Ambler G, Seaman SR, Guttmann O, Elliott PKM. How to develop a more accurate risk prediction model when there are few events. BMJ. 2015;351:h3868.
   PubMed Web of Science ®Google Scholar
• Steyerberg EW, Vickers AJ, Cook N, et al.Assessing the performance of prediction models: a framework for some traditional and novel measures. Epidemiology. 2010;21(1):128. doi:10.1097/EDE.0b013e3181c30fb2
   PubMed Web of Science ®Google Scholar
• Karimi-Alavijeh F, Jalili S, Sadeghi M. Predicting metabolic syndrome using decision tree and support vector machine methods. ARYA Atheroscler. 2016;12:3.
   Google Scholar
• Moons KG, Kengne AP, Woodward M, et al. Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker. Heart. 2012;98(9):683–690.
   PubMed Web of Science ®Google Scholar
• Zhang W, Chen Q, Yuan Z, et al. A routine biomarker-based risk prediction model for metabolic syndrome in urban Han Chinese population. BMC Public Health. 2015;15:64.
   PubMedGoogle Scholar
• Pujos-Guillot E, Brandolini M, Pétéra M, et al. Systems metabolomics for prediction of metabolic syndrome. J Proteome Res. 2017;16(6):2262–2272.
   PubMed Web of Science ®Google Scholar